Bayoumi Y, Sabbagh AJ, Mohamed R, ElShokhaiby UM, Maklad AM, Tunio MA, Balbaid AAO. Clinicopathological features and treatment outcomes of brain stem gliomas in Saudi population. World J Clin Oncol 2014; 5(5): 1060-1067 [PMID: 25493242 DOI: 10.5306/wjco.v5.i5.1060]
Corresponding Author of This Article
Mutahir A Tunio, FCPS (Radiation Oncology), Assistant Consultant, Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Khurais Road, Riyadh-59046, Saudi Arabia. mkhairuddin@kfmc.med.sa
Research Domain of This Article
Oncology
Article-Type of This Article
Original Article
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Ahmed Marzouk Maklad, Clinical Oncology, Sohag University, Sohag 11432, Egypt
Mutahir A Tunio, Ali Abdullah O Balbaid, Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Riyadh-59046, Saudi Arabia
Author contributions: Bayoumi Y and Sabbagh AJ designed the study; Mohamed R, ElShokhaiby UM, Maklad AM and Balbaid AAO collected the data; Mohamed R, Maklad AM and Tunio MA analyzed the data; Mohamed R, Maklad AM and Balbaid AAO wrote the manuscript; Bayoumi Y, Sabbagh AJ, ElShokhaiby UM and Tunio MA, edited the manuscript; Bayoumi Y, Sabbagh AJ, ElShokhaiby UM, Maklad AM and Tunio MA reviewed the manuscript.
Correspondence to: Mutahir A Tunio, FCPS (Radiation Oncology), Assistant Consultant, Radiation Oncology, Comprehensive Cancer Center, King Fahad Medical City, Khurais Road, Riyadh-59046, Saudi Arabia. mkhairuddin@kfmc.med.sa
Telephone: +966-12-889999 Fax: +966-12-889965
Received: February 12, 2014 Revised: April 16, 2014 Accepted: June 10, 2014 Published online: December 10, 2014
Core Tip
Core tip: Brain stem gliomas (BSG) are a heterogeneous group of tumors with a poor prognosis. We analyzed 49 BSG patients from July 2001 to December 2012 with a median age of 12.6 years (range: 8-64 mo). Twenty-two patients (44.9%) had diffuse intrinsic pontine gliomas (DIPG) and 15 (30.6%) presented with focal/tectal BSG. Histopathology was available in 30 patients (61.2%). Median survival time for the whole cohort was 1.5 years. One and two year OS rates were 51.1% and 41.9% respectively. Two year OS rates for focal/tectal, dorsally exophytic, cervicomedullary and DIPG tumors were 60%, 33.3%, 33.3% and 13.6% respectively (P < 0.0001). We concluded that BSG, especially the DIPG subgroup, had a dismal prognosis, needing more aggressive neurosurgical, radiation and chemotherapy techniques, while focal and tectal tumors were found to have a better prognosis.
